Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication

Archives of Internal Medicine

Volumn 170, Issue 12, 2010, Pages 1064-1072

  Tamblyn, Robyn ^a   Abrahamowicz, Michal ^a   Dauphinee, Dale ^a   Wenghofer, Elizabeth ^b   Jacques, André ^d   Klass, Daniel ^c   Smee, Sydney ^e   Eguale, Tewodros ^a   Winslade, Nancy ^a   Girard, Nadyne ^a   Bartman, Ilona ^e   Buckeridge, David L ^a   Hanley, James A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

^c The College of Physicians and Surgeons of Ontario   (Canada)

^d Quebec College of Physicians   (Canada)

^e Medical Council of Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; CLINICAL DECISION MAKING; COMORBIDITY; DISEASE MANAGEMENT; DOCTOR PATIENT RELATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; ANTIHYPERTENSIVE AGENTS; COMMUNICATION; DECISION MAKING; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; QUEBEC; TREATMENT OUTCOME;

EID: 77954203365     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.167     Document Type: Article

References (57)

1. Daar AS, Singer PA, Persad DL, et al. Grand challenges in chronic non-communicable diseases. Nature. 2007;450(7169):494-496.
2. Heron M, Hoyert D, Xu J, Scott C. Deaths: preliminary data for 2006. Natl Vital Stat Rep. 2008;56(12):1-52.
3. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-2398.
4. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26(4):483-492.
5. Perreault S, Lamarre D, Blais L, et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother. 2005;39(9):1401-1408.
6. Bourgault C, Senecal M, Brisson M, Marentette MA, Gregoire JP. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens. 2005;19(8):607-613.
7. Chou CC, Lee MS, Ke CH, Chuang MH. Factors influencing the switch in the use of antihypertensive medications. Int J Clin Pract. 2005;59(1):85-91.
8. Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005;23(11):2093-2100.
9. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177-186.
10. Grégoire JP, Moisan J, Guibert R, et al. Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol. 2002;55(7):728-735.
11. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999;160(1):41-46. (Pubitemid 29054225)
12. Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008;117(22):2884-2892.
13. Banning M. Older people and adherence with medication: a review of the literature. Int J Nurs Stud. 2008;45(10):1550-1561.
14. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
15. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804. doi:10.1002/14651858.CD004804.
16. Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A; Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. J Hypertens. 2000; 18(11):1691-1699.
17. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database Syst Rev. 2009;(3):CD001841. doi:10.1002/14651858.CD001841.pub2.
18. Bokhour BG, Berlowitz DR, Long JA, Kressin NR. How do providers assess antihypertensive medication adherence in medical encounters? J Gen Intern Med. 2006;21(6):577-583.
19. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855-1862.
20. Martin RM, Kerry SM, Hilton SR. Initial treatment choices, second-line therapy, and reasons for stopping medication in the treatment of hypertension by general practitioners in England, Scotland and Wales: 1990-1995. Pharmacoepidemiol Drug Saf. 1997;6(4):253-261.
21. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-1564.
22. Wilson IB, Schoen C, Neuman P, et al. Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors. J Gen Intern Med. 2007;22(1):6-12.
23. Heisler M, Cole I, Weir D, Kerr EA, Hayward RA. Does physician communication influence older patients' diabetes self-management and glycemic control? results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci. 2007;62(12):1435-1442. (Pubitemid 351158373)
24. Golin C, DiMatteo R, Duan N, Leake B, Gelberg L. Impoverished diabetic patients whose doctors facilitate their participation in medical decision making are more satisfied with their care. J Gen Intern Med. 2002;17(11):857-866.
25. Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165(15):1749-1755.
26. Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163(1):83-90.
27. Hulka BS, Cassel JC, Kupper LL, Burdette JA. Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health. 1976;66(9):847-853.
28. DiMatteo MR. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary. 1995;30(10):596-598, 601-602, 605.
29. Haq C, Steele DJ, Marchand L, Seibert C, Brody D. Integrating the art and science of medical practice: innovations in teaching medical communication skills. Fam Med. 2004;36(suppl):S43-S50. (Pubitemid 38182278)
30. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293(10):1223-1238.
31. Reznick RK, Blackmore D, Dauphinee WD, Rothman AI, Smee S. Large-scale highstakes testing with an OSCE: report from the Medical Council of Canada. Acad Med. 1996;71(1)(suppl):S19-S21.
32. Wenghofer E, Klass D, Abrahamowicz M, et al. Doctor scores on national qualifying examinations predict quality of care in future practice. Med Educ. 2009; 43(12):1166-1173.
33. Tamblyn R, Abrahamowicz M, Dauphinee D, et al. Physician scores on a national clinical skills examination as predictors of complaints to medical regulatory authorities. JAMA. 2007;298(9):993-1001.
34. Tamblyn R, Abrahamowicz M, Dauphinee WD, et al. Association between licensure examination scores and practice in primary care. JAMA. 2002;288(23):3019-3026.
35. Regie de l'assurance-maladie du Quebec. Statistiques Annuelles. Quebec, QC: Regie de l'assurance-maladie du Quebec; 2000. Report ISBN 2-550-30856-5.
36. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11(7):449-457. (Pubitemid 41022729)
37. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105-116.
38. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37(9):846-857.
39. Medical Council of Canada. Clinical stations. Medical Council of Canada Web site. 2009. http://www.mcc.ca/en/exams/qe2/clinical-stations.shtml. Accessed June 2005.
40. Mandin H, Dauphinee WD. Conceptual guidelines for developing and maintaining curriculum and examination objectives: the experience of the Medical Council of Canada. Acad Med. 2000;75(10):1031-1037.
41. Page G, Bordage G, Allen T. Developing key-feature problems and examinations to assess clinical decision-making skills. Acad Med. 1995;70(3):194-201.
42. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995;48(8):999-1009.
43. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421-429.
44. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
45. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44(4):1049-1060.
46. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99(5):325-332.
47. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57(2):131-141.
48. Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension: a systems approach. Am J Hypertens. 2004;17(10):921-927.
49. Goff SL, Mazor KM, Meterko V, Dodd K, Sabin J. Patients' beliefs and preferences regarding doctors' medication recommendations. J Gen Intern Med. 2008;23(3):236-241.
50. Hauber AB, Mohamed AF, Johnson FR, Falvey H. Treatment preferences and medication adherence of people with type 2 diabetes using oral glucose-lowering agents. Diabet Med. 2009;26(4):416-424.
51. Chessare JB. Teaching clinical decision-making to pediatric residents in an era of managed care. Pediatrics. 1998;101(4, pt 2):762-767.
52. Ogur B, Hirsh D, Krupat E, Bor D. The Harvard Medical School-Cambridge integrated clerkship: an innovative model of clinical education. Acad Med. 2007;82(4):397-404.
53. Reidel K, Tamblyn R, Patel V, Huang A. Pilot study of an interactive voice response system to improve medication refill compliance. BMC Med Inform Decis Mak. 2008;8(1):46.
54. Green BB, Ralston JD, Fishman PA, et al. Electronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation framework. Contemp Clin Trials. 2008;29(3):376-395.
55. Fursse J, Clarke M, Jones R, Khemka S, Findlay G. Early experience in using telemonitoring for the management of chronic disease in primary care. J Telemed Telecare. 2008;14(3):122-124.
56. Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care. 2001;24(2):202-208. (Pubitemid 32119112)
57. Oake N, Jennings A, van Walraven C, Forster AJ. Interactive voice response systems for improving delivery of ambulatory care. Am J Manag Care. 2009;15(6):383-391.